Sign in
4

Changes in Ownership

Natera, Inc. Filed Acc 0001415889-25-011882

PRESIDENT, CLINICALDIAGNOSTICS sold 3,000 shares at an average $150.12 ($450,353)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moshkevich Solomon · PRESIDENT, CLINICALDIAGNOSTICS

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-01 Sale : show line 1 in the form 10b5-1 −853 $148.25 $126,460 138,352 D
2025-05-01 Sale : show line 2 in the form 10b5-1 −908 $149.99 $136,188 137,444 D
2025-05-01 Sale : show line 3 in the form 10b5-1 −908 $151.30 $137,379 136,536 D
2025-05-01 Sale : show line 4 in the form 10b5-1 −331 $152.04 $50,325 136,205 D
Open-market sales · 3,000 sh · avg $150.12 · $450,353
Loading xslF345X05/form4-05022025_090504.xml…